Curanex PharmaceuticalsCURX
13F holders, Q2 2026 (June 30)At the end of Q2 2026, 11 institutions reported holding Curanex Pharmaceuticals Inc. (CURX) in their 13F filings, up 3 from Q1 2026. 6 opened new positions and 3 sold out. The largest holders were Citadel Advisors ($25K), Virtu Financial LLC ($14K) and Renaissance Technologies ($14K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Curanex Pharmaceuticals Inc.
- CUSIP
- 23126K106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $44K |
| Exits | 3 | $61K |
All 13F filers, Q1 2026 → Q2 2026: 214,545 shares bought and 208,197 shares sold, net +6,348 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Citadel Advisors | 0.00% | Add +88.4% | 95,258 | $25K |
| Virtu Financial LLC | 0.00% | New | 51,236 | $14K |
| Renaissance Technologies | 0.00% | New | 52,000 | $14K |
| Geode Capital Management, LLC | 0.00% | Reduce -65.5% | 38,288 | $10K |
| Jane Street Group, LLC | 0.00% | New | 31,215 | $8K |
| Two Sigma Investments, LP | 0.00% | Add +35.0% | 27,354 | $7K |
| Susquehanna International Group, LLP | 0.00% | New | 14,657 | $4K |
| Ground Swell Capital, LLC | 0.00% | New | 12,638 | $3K |
| Citigroup Inc. | 0.00% | Reduce -53.7% | 8,957 | $2K |
| UBS Group AG | 0.00% | Reduce -81.2% | 1,506 | $400 |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1,000 | $265 |
"% of holder's portfolio" is CURX's weight in each manager's 13F, not the share of Curanex Pharmaceuticals Inc. the manager owns.